Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin vs glimepiride cardiovascular outcomes in type 2 diabetes mellitus
jRCT2080221393Phase 3Completed
- Start
- Mar 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of linagliptin in type 2 diabetes mellitus (T2DM) and cardiac morbidity (2 arms). Primary endpoint: Time to first 3-point MACE. Started Mar 2011; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)cardiac morbidity
Beyond the preview
Go deeper on jRCT2080221393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221393.